Paroxetine-Induced Apoptosis in Human Osteosarcoma Cells: Activation of P38 Map Kinase and Caspase-3 Pathways Without Involvement of [ca2+](i) Elevation

Xue Liang,Wei Sen Zhang,Ya Li Jin,Chao Qiang Jiang,Feng Zhu,Kar Keung Cheng,Tai Hing Lam,Lin Xu
DOI: https://doi.org/10.1016/j.taap.2006.11.012
IF: 4.46
2006-01-01
Toxicology and Applied Pharmacology
Abstract:Selective serotonin reuptake inhibitors (SSRIs), a group of antidepressants, are generally used for treatment of various mood and anxiety disorders. There has been much research showing the anti-tumor and cytotoxic activities of some antidepressants; but the detailed mechanisms were unclear. In cultured human osteosarcoma cells (MG63), paroxetine reduced cell viability in a concentration- and time-dependent manner. Paroxetine caused apoptosis as assessed by propidium iodide-stained cells and increased caspase-3 activation. Although immunoblotting data revealed that paroxetine could activate the phosphorylation of extracellular signal-regulated kinase (ERK), c-Jun NH(2)-terminal kinase (JNK) and p38 mitogen-activated protein kinase (p38 MAPK), only SB203580 (a p38 MAPK inhibitor) partially prevented cells from apoptosis. Paroxetine also induced [Ca(2+)](i) increases which involved the mobilization of intracellular Ca(2+) stored in the endoplasmic reticulum and Ca(2+) influx from extracellular medium. However, pretreatment with BAPTA/AM, a Ca(2+) chelator, to prevent paroxetine-induced [Ca(2+)](i) increases did not protect cells from death. The results suggest that in MG63 cells, paroxetine caused Ca(2+)-independent apoptosis via inducing p38 MAPK-associated caspase-3 activation.
What problem does this paper attempt to address?